Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer.
about
Surgical resection versus non-surgical treatment for hepatic node positive patients with colorectal liver metastasesHepatic resection, hepatic arterial infusion pump therapy, and genetic biomarkers in the management of hepatic metastases from colorectal cancerA phase 1 study of hepatic arterial infusion of oxaliplatin in combination with systemic 5-fluorouracil, leucovorin, and bevacizumab in patients with advanced solid tumors metastatic to the liver.Evolution in the treatment of metastatic colorectal carcinoma of the liverColorectal liver metastasesProspective evaluation of 18F-fluorodeoxyglucose positron emission tomography in patients receiving hepatic arterial and systemic chemotherapy for unresectable colorectal liver metastases.Phase II trial of hepatic artery infusional and systemic chemotherapy for patients with unresectable hepatic metastases from colorectal cancer: conversion to resection and long-term outcomes.What is the potential role of hepatic arterial infusion chemo-therapy in the current armamentorium against colorectal cancer.Simultaneous resection for rectal cancer with synchronous liver metastasis is a safe procedure.Hepatic arterial infusion of chemotherapy for hepatic metastases from colorectal cancer.Management of the hepatic lymph nodes during resection of liver metastases from colorectal cancer: a systematic review.Colorectal liver metastases: current and future perspectives.Unresectable intrahepatic cholangiocarcinoma: Systemic plus hepatic arterial infusion chemotherapy is associated with longer survival in comparison with systemic chemotherapy alone.Chemotherapy for colorectal cancer in the metastatic and adjuvant setting: past, present and future.Recent advances and significance of intra-arterial infusion chemotherapy in non-resectable colorectal liver metastasis.Conversion to resectability using hepatic artery infusion plus systemic chemotherapy for the treatment of unresectable liver metastases from colorectal carcinomaModern prospection for hepatic arterial infusion chemotherapy in malignancies with liver metastasesNeoadjuvant chemotherapy for patients with liver metastases from colorectal cancer.First-line treatment with hepatic arterial infusion plus capecitabine vs capecitabine alone for elderly patients with unresectable colorectal liver metastasesThe role of aggressive regional therapy for colorectal liver metastases.A phase I trial of isolated hepatic perfusion (IHP) using 5-FU and oxaliplatin in patients with unresectable isolated liver metastases from colorectal cancer.Regional chemotherapy for unresectable primary liver cancer: results of a phase II clinical trial and assessment of DCE-MRI as a biomarker of survival.Role of intra-arterial hepatic chemotherapy in the treatment of colorectal cancer metastases.Advances in regional chemotherapy of the liver.Arterial therapies of colorectal cancer metastases to the liver.Chinese guidelines for the diagnosis and comprehensive treatment of hepatic metastasis of colorectal cancer.Clinical significance of and future perspectives for hepatic arterial infusion chemotherapy in patients with liver metastases from colorectal cancer.Floxuridine hepatic arterial infusion associated biliary toxicity is increased by concurrent administration of systemic bevacizumab.Hepatic arterial infusion pump chemotherapy for colorectal liver metastases: an old technology in a new era.Regional Delivery of Chimeric Antigen Receptor (CAR) T-Cells for Cancer Therapy.The state of regional therapy in the management of metastatic colorectal cancer to the liver.Treatment Options in Colorectal Liver Metastases: Hepatic Arterial Infusion.Hepatic arterial infusion plus systemic chemotherapy as third-line or later treatment in colorectal liver metastases.Hepatic arterial infusion pump chemotherapy in the management of colorectal liver metastases: expert consensus statement.Complete eradication of hepatic metastasis from colorectal cancer by Yttrium-90 SIRT.The outcome of liver resection and lymphadenectomy for hilar lymph node involvement in colorectal cancer liver metastases.Prospective phase II trial of combination hepatic artery infusion and systemic chemotherapy for unresectable colorectal liver metastases: Long term results and curative potential.Effectiveness of Hepatic Artery Infusion (HAI) Versus Selective Internal Radiation Therapy (Y90) for Pretreated Isolated Unresectable Colorectal Liver Metastases (IU-CRCLM).Perioperative Hepatic Arterial Infusion Pump Chemotherapy Is Associated With Longer Survival After Resection of Colorectal Liver Metastases: A Propensity Score Analysis.Conversion to complete resection and/or ablation using hepatic artery infusional chemotherapy in patients with unresectable liver metastases from colorectal cancer: a decade of experience at a single institution.
P2860
Q24241019-9E58843E-612E-495C-8E2F-0BAEA916258CQ26772267-49349303-0975-4DA7-8773-FE2444FC2D8EQ33390290-B7D0B8A8-6F33-4890-A267-9F3C2A5E68CAQ33868416-17176842-FEA0-4C2B-98DE-FCB11291416EQ35687594-4C040943-2701-4E87-A3D9-8DE73D579EB1Q35761121-8A3FF288-2227-458A-A1F0-E4C1725A91F2Q36083102-4CD0F3DA-EFD7-4CA8-AF3A-000B21EDC3A1Q36097254-014DE1A1-CC23-441D-B62A-D01A5180595DQ36155919-76F9AB55-FA45-4ACC-B690-817E8E5381E9Q36409952-73130820-4910-4DA1-B478-F5B65E19D782Q36470638-46B7C50A-1C9E-4036-9CD1-57CC87BC76D8Q36572540-58DB05E1-F9CA-4B4F-83EE-8E7896B7EFB1Q36609503-9221AB1E-925D-484B-98C1-FEC8FA6A6A38Q36788478-4F9CCB82-13A5-4DB4-9A93-79ED4A1330E1Q36792353-8BD70A08-15EC-475F-B7D5-1BB0CD24D1B4Q36822114-DD6EBF4F-209E-4947-88BF-487736DFA454Q36838134-96D10483-CDCD-435D-BA89-0063BA3525BCQ36842791-8F681FCA-D716-4F98-A1D4-75B095FA0735Q36843737-D2CD3B2B-A79C-4304-B116-5B842D28D39AQ36946762-ADA43825-4F4A-466D-9A5F-01903AE26959Q37254998-1CC29730-D9E8-49EF-B5A2-2C89D3BD30CAQ37316228-ED92263A-2417-42DC-B451-186D2DB292F4Q37821853-73DD3A9C-638D-451F-982E-ED2A0E475933Q37867126-551F54BA-DCEB-437D-A1A3-2D87C5C4E145Q37890914-68CEAA35-668D-4409-9613-73CE4D5B0D67Q37907117-AC6CC9DC-F796-481D-AE17-0F5A8AB87467Q38059122-5D83A09A-FE74-40A2-96EB-E23604EAF84FQ38155097-FAE5D144-8B8A-455D-B012-0AB094B5F8A7Q38187647-D555480D-8E6A-4387-93BA-959DE4A5ED94Q38656009-01CA6E18-4F81-4464-9DAD-C225BFB2D402Q38664762-1BCF5322-B0E0-4D3D-ACA4-DFF3A3607109Q39371177-BD37244A-4F88-4595-B70E-5AB0C8436ACFQ41685632-784C6A75-17C5-4020-A936-6E234AD5D9E5Q41946954-325DC987-2AC8-4A48-B7F3-25597B1A77C7Q42013913-94D30393-F7DE-4E1B-BCC7-AEFCF54426C2Q45129979-632166EB-F9F0-4CA2-9BA7-A091B2098F5DQ48254405-5F9141A6-1397-4319-8719-04D4AC136B7FQ49580491-F6141CBA-B86E-451A-BAC5-601D9CB14954Q50909114-48FAD032-A057-4A1F-9E7F-068F9F550217Q51804221-A62E1EFD-002F-49EB-BC7A-91E59CF4C05D
P2860
Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Phase I trial of systemic oxal ...... stases from colorectal cancer.
@ast
Phase I trial of systemic oxal ...... stases from colorectal cancer.
@en
Phase I trial of systemic oxal ...... stases from colorectal cancer.
@nl
type
label
Phase I trial of systemic oxal ...... stases from colorectal cancer.
@ast
Phase I trial of systemic oxal ...... stases from colorectal cancer.
@en
Phase I trial of systemic oxal ...... stases from colorectal cancer.
@nl
prefLabel
Phase I trial of systemic oxal ...... stases from colorectal cancer.
@ast
Phase I trial of systemic oxal ...... stases from colorectal cancer.
@en
Phase I trial of systemic oxal ...... stases from colorectal cancer.
@nl
P2093
P50
P921
P356
P1476
Phase I trial of systemic oxal ...... stases from colorectal cancer.
@en
P2093
Gregory Leonard
Lawrence Schwartz
Leslie Blumgart
Meroë Morse
Michael D'Angelica
Mithat Gönen
Nancy Kemeny
Philip Paty
Ronald DeMatteo
P304
P356
10.1200/JCO.2005.07.100
P407
P577
2005-07-11T00:00:00Z